- Home
- BBN vs MDXG Comparison
BBN vs MDXG Comparison
Compare BBN & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBN | MDXG |
|---|---|---|
| Founded | 1983 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 996.7M | 530.2M |
| IPO Year | 2010 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BBN | MDXG |
|---|---|---|
| Price | $16.03 | $3.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 158.6K | ★ 1.9M |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | ★ 6.90% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $15.38 | $3.03 |
| 52 Week High | $17.45 | $7.99 |
Technical Indicators
Market Signals| Indicator | BBN | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 35.04 | 46.02 |
| Support Level | $15.58 | $3.11 |
| Resistance Level | $16.69 | $7.39 |
| Average True Range (ATR) | 0.14 | 0.17 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 0.00 | 75.18 |
Price Performance
Historical ComparisonAbout BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest
BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation. The Trust seeks to achieve its investment objectives by investing in a portfolio of taxable municipal securities, including Build America Bonds (BABs), issued by state and local governments to finance capital projects such as public schools, roads, transportation infrastructure, bridges, ports and public buildings.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.